Abstract

BackgroundNear-IR fluorescence (NIRF) imaging is becoming a promising approach in preclinical tumor detection and clinical image-guided oncological surgery. While heptamethine cyanine dye IR780 has excellent tumor targeting and imaging potential, its hydrophobic property limits its clinical use. In this study, we developed nanoparticle formulations to facilitate the use of IR780 for fluorescent imaging of malignant brain tumor.MethodsSelf-assembled IR780-liposomes and IR780-phospholipid micelles were prepared and their NIRF properties were characterized. The intracellular accumulation of IR780-nanoparticles in glioma cells were determined using confocal microscopy. The in vivo brain tumor targeting and NIRF imaging capacity of IR780-nanoparticles were evaluated using U87MG glioma ectopic and orthotopic xenograft models and a spontaneous glioma mouse model driven by RAS/RTK activation.ResultsThe loading of IR780 into liposomes or phospholipid micelles was efficient. The particle diameter of IR780-liposomes and IR780-phospholipid micelles were 95 and 26 nm, respectively. While stock solutions of each preparation were maintained at ready-to-use condition, the IR780-phospholipid micelles were more stable. In tissue culture cells, IR780-nanoparticles prepared by either method accumulated in mitochondria, however, in animals the IR780-phospholipid micelles showed enhanced intra-tumoral accumulation in U87MG ectopic tumors. Moreover, IR780-phospholipid micelles also showed preferred intracranial tumor accumulation and potent NIRF signal intensity in glioma orthotopic models at a real-time, non-invasive manner.ConclusionThe IR780-phospholipid micelles demonstrated tumor-specific NIRF imaging capacity in glioma preclinical mouse models, providing great potential for clinical imaging and image-guided surgery of brain tumors.

Highlights

  • Near-IR fluorescence (NIRF) imaging is becoming a promising approach in preclinical tumor detection and clinical image-guided oncological surgery

  • The insertion of IR780 into liposomes or phospholipid micelles caused the bathochromic shift of the absorption band and decreased absorbance

  • While the Blood–brain barrier (BBB) is a natural challenge for drug delivery to brain tumors, our results show that IR780-phospholipid micelles could efficiently reach U87M2/luc orthotopic tumors 24 h post injection

Read more

Summary

Introduction

Near-IR fluorescence (NIRF) imaging is becoming a promising approach in preclinical tumor detection and clinical image-guided oncological surgery. Several formulations of IR780-encapsulated nanoparticles have been investigated, such as the heparin-folic acid conjugate [17], biodegradable human serum albumin nanoparticles [15], transferrin nanoparticles [16], poly(n-butyl cyanoacrylate) nanocapsules [18], poly(styrene-alt-maleic anhydride)-based diblock copolymer micelles [19], rhenium-188 labeled methoxy poly(ethylene glycol)-block-poly(ε-caprolactone) copolymeric micelles [20], pH-responsive polymeric prodrug micelles [21], phospholipid mimicking homopolymeric micelles [22], bubble-generating folate-targeted liposomes [23], and amsacrine analog-loaded solid lipid nanoparticle [24] Most of these carriers were designed for both diagnostic and therapeutic purpose, rarely for fulfilling the unique requirement of NIRF imaging or tumor detection

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call